½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸ Echo Seoul & Cardiac Imaging 2022(1ÀÏÂ÷) : 2022-10-15±³À°ÀÏÀÚ : 2022-10-15
±³À°Àå¼Ò : »ï¼º»ý¸í ÀÏ¿ø¿ªºôµù Bµ¿ 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦
±³À°ÁÖÁ¦ :
(¿Â,¿ÀÇÁ¶óÀÎ µ¿½Ã°³ÃÖ) Echo Seoul & Cardiac Imaging 2022(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀåÇ÷°ü¿µ»ó¿¬±¸È¸
´ã´çÀÚ : Àå½ÅÀÌ
¿¬¶ôó : 02-3410-2754
À̸ÞÀÏ :
bautai.jang@samsung.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ÇÙÀÇÇаú
Âü¼®¿¹»óÀοø : 400¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 10ºÐ
¼¼ºÎ¼ö°·á : 90,000¿ø
ºñ°í Àü¹®ÀÇ, °³¿øÀÇ, °øÁߺ¸°ÇÀÇ, ±ºÀÇ°ü: ¿Â¶óÀÎ 50000 / ÇöÀå 90000ÀüÀÓÀÇ, »ê¾÷ü, ±âŸ: ¿Â¶óÀÎ 30000 / ÇöÀå 70000Àü°øÀÇ, ÀÎÅÏ, Sonographer, °£È£»ç, ¹æ»ç¼±»ç, ÀÓ»óº´¸®»ç, Çлý: ¿Â¶óÀÎ 20000 / ÇöÀå 70000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 08:35~08:50 Cardiac Imaging in the evaluation of HCM ±èÇü°ü(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 08:50~09:05 Sudden cardiac death risk in HCM What should we consider? S. Ommen((¹Ì) ¸ÞÀÌ¿äŬ¸®´Ð)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:05~09:20 Septal reduction therapy: current trends ±è¿í¼º(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:20~09:35 HCM genetics, tissue characterization and atriopathy ÃÖÀÇ¿µ(¿¬¼¼ÀÇ´ë)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 09:35~09:50 Panel discussion ¼ÕÀϼ® ±èÇüÀ± ȲÁö¿ø ÃÖÀÚ¿¬(´Ù¼Ò¼Ó)
ÈÞ½Ä 10-15 9Ãþ °ÀǽÇ(¿¹,Áö) 09:50~10:00 Break ()
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:00~10:15 Understanding hemodynamics in heart failure ±è´Ù·¡(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:15~10:30 Exercise catheterization with simultaneous echocardiography Masaru Obokata((ÀÏ) ±º¸¶ÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:30~10:45 Diastolic function and clinical decision making in critically ill patients ÇÏÁ¾¿ø(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 10:45~11:00 Invasive hemodynamic asessment in HFpEF ¾çÁ¤ÈÆ(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:00~11:15 Panel discussion ½Å¼ºÈñ ÃÖ¼ºÈÆ ÃÖÁ¤Çö ±è¼ºÈ¯(´Ù¼Ò¼Ó)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:15~11:55 Echocardiography as the Hemodynamic Gold standard ¿ÀÀç°Ç((¹Ì) ¸ÞÀÌ¿äŬ¸®´Ð)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 11:55~12:10 Questions the audience ¼Õ´ë¿ø ¿ÀÀç°Ç(´Ù¼Ò¼Ó)
½Ä»ç 10-15 9Ãþ °ÀǽÇ(ÀÇ) 12:10~13:10 Lunch time ()
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:10~13:25 What we can see and what we cannot see using echocardiograph À±¿¬ÀÌ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:25~13:40 Uncover hidden myocardial change in systemic disease using CMR mapping ±èÁø¿µ-Online(°è¸íÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:40~13:55 CMR radiomics: New imaging signatures of cardiomyopathy È«À¯Áø-Online(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 13:55~14:10 What's new in nuclear imaging for cardiomyopathy? ÆØÁøö(¼¿ïÀÇ´ë)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:10~14:25 Panel discussion ÃÖÁø¿À ±è¹Ì³ª ÀÌÁÖÈñ ¼Á¤ÈÆ(´Ù¼Ò¼Ó)
ÈÞ½Ä 10-15 9Ãþ °ÀǽÇ(¿¹,Áö) 14:25~14:40 Break ()
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:40~14:55 The role of Echocardiography as the primary imaging modality for the evaluation of pericardial disease Á¶Àͼº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 14:55~15:10 What's next? Cardiac CT or Cardiac MRI Â÷¹ÎÀç-Online(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:10~15:25 The role of FDG-PET in the evaluation of pericardial disease ÃÖÁØ¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:25~15:40 Cases with the utilization of multi-modality imaging ȲÀÎâ(¼¿ïÀÇ´ë)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 15:40~15:55 Panel discussion ÀüÀºÁÖ Çã¶õ ±è¼Ò¸® °¿øÁØ(´Ù¼Ò¼Ó)
ÈÞ½Ä 10-15 9Ãþ °ÀǽÇ(¿¹,Áö) 15:55~16:05 Break ()
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:05~16:20 Pulmonary valvular disease: Treament planning based on echocardiography ÃÖÈ«¹Ì(ºÐ´ç¼¿ï´ëº´¿ø)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:20~16:35 Diagnosis and assassment of RV disease : multimodality insight ±è¼º¸ñ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:35~16:50 How can we apply RV strain to clinical practice? ÀÌÇöÁ¤(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 16:50~17:05 Exercise induced pulmonary hypertension revisited À强¾Æ(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-15 9Ãþ È÷Æ÷Å©¶óÅ×½ºÈ¦ 17:05~17:20 Panel discussion Á¶ÀºÁ¤ À±ÇöÁÖ ¹ÚÀçÇü Á¶µ¿Çõ(´Ù¼Ò¼Ó)